Lab-on-a-Cable for electrochemical monitoring of phenolic contaminants

Triboelectric Nanogenerators for Self-Powered Degradation of Chemical Pollutants

Environmental and human health is severely threatened by wastewater and air pollution, which contain a broad spectrum of organic and inorganic pollutants. Organic contaminants include dyes, volatile organic compounds (VOCs), medical waste, antibiotics, pesticides, and chemical warfare agents. Inorganic gases such as CO2, SO2, and NO x are commonly found in polluted water and air. Traditional methods for pollutant removal, such as oxidation, physicochemical techniques, biotreatment, and enzymatic decomposition, often prove to be inefficient, costly, or energy-intensive. Contemporary solutions like nanofiber-based filters, activated carbon, and plant biomass also face challenges such as generating secondary contaminants and being time-consuming. In this context, triboelectric nanogenerators (TENGs) are emerging as promising alternatives. These devices harvest ambient mechanical energy and convert it to electrical energy, enabling the self-powered degradation of chemical pollutants. This Review summarizes recent progress and challenges in using TENGs as self-powered electrochemical systems (SPECs) for pollutant degradation via photocatalysis or electrocatalysis. The working principles of TENGs are discussed, focusing on their structural flexibility, operational modes, and ability to capture energy from low-frequency mechanical stimuli. The Review concludes with perspectives and suggestions for future research in this field, hoping to inspire further interest and innovation in developing TENG-based SPECs, which represent sustainable and eco-friendly solutions for pollutant treatment.

Trace assay of insulin in a pharmacy drug with a paste electrode

This paper describes the development of a voltammetric assay of insulin using a DNA immobilized onto a carbon nanotube paste electrode (CNPE), the peak potential of which was 0.2 V, vs. Ag/AgCl on the CNPE. The cyclic voltammetry (CV) and square-wave (SW) stripping voltammetry parameters of the optimized conditions were determined. Low analytical working ranges of 10-80 ugL-1 CV and 0.01-0.1 ngL-1 SW were attained. The precision of the insulin concentration of 0.01 ugL-1 was 0.14 (n = 15) RSD using the optimum conditions, in which the detection limit was 0.004 ngL-1 (6.9 × 10-12 M) (S/N = 3) using only an accumulation time of 400 s. The developed method was applied to determine insulin in a pharmacy drug from analytical-grade chemicals (from Aldrich).

A Review of 3D-Printing of Microneedles

Microneedles are micron-sized devices that are used for the transdermal administration of a wide range of active pharmaceutics substances with minimally invasive pain. In the past decade, various additive manufacturing technologies have been used for the fabrication of microneedles; however, they have limitations due to material compatibility and bioavailability and are time-consuming and expensive processes. Additive manufacturing (AM), which is popularly known as 3D-printing, is an innovative technology that builds three-dimensional solid objects (3D). This article provides a comprehensive review of the different 3D-printing technologies that have the potential to revolutionize the manufacturing of microneedles. The application of 3D-printed microneedles in various fields, such as drug delivery, vaccine delivery, cosmetics, therapy, tissue engineering, and diagnostics, are presented. This review also enumerates the challenges that are posed by the 3D-printing technologies, including the manufacturing cost, which limits its viability for large-scale production, the compatibility of the microneedle-based materials with human cells, and concerns around the efficient administration of large dosages of loaded microneedles. Furthermore, the optimization of microneedle design parameters and features for the best printing outcomes is of paramount interest. The Food and Drug Administration (FDA) regulatory guidelines relating to the safe use of microneedle devices are outlined. Finally, this review delineates the implementation of futuristic technologies, such as artificial intelligence algorithms, for 3D-printed microneedles and 4D-printing capabilities.

Real-time Detection of Trace Copper in Brain and Kidney of Fish for Medical Diagnosis

For the detection of trace copper to be used in medical diagnosis, a sensitive handmade carbon nanotube paste electrode (PE) was developed using voltammetry. Analytical optimized conditions were found at 0.05 V anodic peak current. In the same conditions, various common electrodes were compared using stripping voltammetry, and the PE was found to be more sharply sensitive than other common electrodes. At optimum conditions, the working ranges of 3~19 μgL⁻¹ were obtained. The relative standard deviation of 70.0 μgL⁻¹ was determined to be 0.117% (n = 15), and the detection limit (S/N) was found to be 0.6 μgL⁻¹ (9.4 × 10⁻⁹ M). The results were applied in detecting copper traces in the kidney and the brain cells of fish.

Nanomedicines for back of the eye drug delivery, gene delivery, and imaging

Treatment and management of diseases of the posterior segment of the eye such as diabetic retinopathy, retinoblastoma, retinitis pigmentosa, and choroidal neovascularization is a challenging task due to the anatomy and physiology of ocular barriers. For instance, traditional routes of drug delivery for therapeutic treatment are hindered by poor intraocular penetration and/or rapid ocular elimination. One possible approach to improve ocular therapy is to employ nanotechnology. Nanomedicines, products of nanotechnology, having at least one dimension in the nanoscale include nanoparticles, micelles, nanotubes, and dendrimers, with and without targeting ligands. Nanomedicines are making a significant impact in the fields of ocular drug delivery, gene delivery, and imaging, the focus of this review. Key applications of nanotechnology discussed in this review include a) bioadhesive nanomedicines; b) functionalized nanomedicines that enhance target recognition and/or cell entry; c) nanomedicines capable of controlled release of the payload; d) nanomedicines capable of enhancing gene transfection and duration of transfection; f) nanomedicines responsive to stimuli including light, heat, ultrasound, electrical signals, pH, and oxidative stress; g) diversely sized and colored nanoparticles for imaging, and h) nanowires for retinal prostheses. Additionally, nanofabricated delivery systems including implants, films, microparticles, and nanoparticles are described. Although the above nanomedicines may be administered by various routes including topical, intravitreal, intravenous, transscleral, suprachoroidal, and subretinal routes, each nanomedicine should be tailored for the disease, drug, and site of administration. In addition to the nature of materials used in nanomedicine design, depending on the site of nanomedicine administration, clearance and toxicity are expected to differ.

Assay of In Vivo Chromium with a Hollow-fiber Dialysis Sensor

The analytical in vivo chromium ion was searched for using a voltammetric hollow-fiber dialysis sensor via square wave stripping voltammetry (SW) , cyclic voltammetry (CV) , and chronoamperometry. Under optimum parameters, the analytical results indicated linear working ranges of 50~400 mg/l CV and 10~80 μg/l SW within a 30-sec accumulation time. The analytical detection limit (S/N) was 6.0 μg/l. The developed method can be applied to in vivo tissues and in ex vivo toxicity assay, as well as to other materials that require chromium analysis.

Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety

Many promising therapeutic agents are limited by their inability to reach the systemic circulation, due to the excellent barrier properties of biological membranes, such as the stratum corneum (SC) of the skin or the sclera/cornea of the eye and others. The outermost layer of the skin, the SC, is the principal barrier to topically-applied medications. The intact SC thus provides the main barrier to exogenous substances, including drugs. Only drugs with very specific physicochemical properties (molecular weight < 500 Da, adequate lipophilicity, and low melting point) can be successfully administered transdermally. Transdermal delivery of hydrophilic drugs and macromolecular agents of interest, including peptides, DNA, and small interfering RNA is problematic. Therefore, facilitation of drug penetration through the SC may involve by-pass or reversible disruption of SC molecular architecture. Microneedles (MNs), when used to puncture skin, will by-pass the SC and create transient aqueous transport pathways of micron dimensions and enhance the transdermal permeability. These micropores are orders of magnitude larger than molecular dimensions, and, therefore, should readily permit the transport of hydrophilic macromolecules. Various strategies have been employed by many research groups and pharmaceutical companies worldwide, for the fabrication of MNs. This review details various types of MNs, fabrication methods and, importantly, investigations of clinical safety of MN.

Voltammetric Assay of Mercury Ion in Fish Kidneys

Voltammetric analysis of mercury ions was developed using paste electrodes (PEs) with DNA and carbon nanotube mixed electrodes. The optimized analytical results of the cyclic voltammetry (CV) of the 1∼14 ng L⁻¹ Hg(II) concentration and the square wave (SW) stripping voltammetry of the 1∼12 ng L⁻¹ Hg(II) working range within an accumulation time of 400 seconds were obtained in 0.1 M NH₄H₂PO₄ electrolyte solutions of pH 4.0. For the relative standard deviations of the 1 ng L⁻¹ Hg(II), which were observed at 0.078% (n = 15) at the optimum conditions, the low detection limit (S/N) was pegged at 0.2 ng L⁻¹ (7.37 × 10⁻¹³M) for Hg(II). The results can be applied to assays in biological fish kidneys and wastewater samples.

Detection of dopamine in the pharmacy with a carbon nanotube paste electrode using voltammetry

A simply prepared DNA immobilized on a carbon nanotube paste electrode (CNTPE) was utilized to monitor dopamine ion concentration using the cyclic voltammetry (CV) and square-wave (SW) stripping voltammetry methods. The optimum analytical conditions were sought. The result obtained was a very low detection limit compared to other common voltammetry methods. The optimal parameters were found to be as follows: 3.5 pH, 0.48 V SW amplitude, 71 Hz frequency, 5 s accumulation time, 0.01 V increment potential, and -1.3 V (anodic-*-) and 1.2 V (cathodic-o-) accumulation potentials. Given these conditions, the linear working range was observed to be within 0.01-0.11 microg L(-1) (SW anodic and CV). The analytical detection limit was determined to be SW anodic and CV: 4.0 microg L(-1) (2.1 x 10(-11) mol L(-1)) dopamin, and the relative standard deviation at the dopamine concentration of SW anodic 0.05 microg L(-1) was 0.02% (n=15) at the optimum conditions.

Electrochemical biosensors for environmental monitoring

Highly sensitive electrochemical biosensors offer precision, sensitivity, rapidity, and ease of operation for on-site environmental analysis. An electrochemical biosensor is an analytical device in which a specific biological recognition element (bioreceptor) is integrated within or intimately associated with an electrode (transducer) that converts the recognition event to a measurable electrical signal for the purpose of detecting a target compound (analyte) in solution. The signal generated allows both qualitative and quantitative measurements of an analyte in real time. In most cases, a miniaturized electrochemical cell contains a low volume of analyte, which is vital when dealing with hazardous materials and makes such devices ideal for environmental monitoring. This approach not only provides the means for on-site analysis but also removes the time delay and sample alteration that can occur during transport to a centralized laboratory. We first address the basic principles of electroanalytical measurement and the merger of electrochemistry and biology into a biosensing system, and then we discuss various environmental monitoring strategies involving this technology.

The analysis of uric acid in urine using microchip capillary electrophoresis with electrochemical detection

Clinical studies have linked irregular concentrations of uric acid in urine to several diseases. Conventional methods for the measurement of uric acid are however temperature-dependent, expensive, and require labile reagents. The miniaturization of analytical techniques, specifically capillary electrophoresis, offers an ideal alternative for clinical analyses such as uric acid determination. The added benefits include reduced reagent and analyte consumption, decreased maintenance costs, and increased throughput and portability. A microchip capillary electrophoresis-electrochemical system for the analysis of uric acid in urine is described. The poly(dimethylsiloxane) (PDMS)/glass microchip utilizes amperometric detection via an off-chip platinum working electrode. Linear responses from 1 to 165 microM and 15 to 110 microM were found for dopamine and uric acid, respectively. The limit of detection for both compounds was 1 microM. Once characterized, the system was used to measure the concentration of uric acid in a dilute urine sample in less than 30 s. The measured uric acid concentration was verified with the uricase reaction and found to be acceptable. Six additional urine samples were evaluated with the microchip device and the uric acid concentration for each sample was found to be in the expected clinical concentration range.

Amplification of amperometric biosensor responses by electrochemical substrate recycling. 3. Theoretical and experimental study of the phenol-polyphenol oxidase system immobilized in Laponite hydrogels and layer-by-layer self-assembled structures

The amperometric response toward phenol of PPO-based rotating disk bioelectrodes is analyzed on the basis of a kinetic model taking into account internal and external mass transport effects and a CEC' electroenzymatic mechanism. Monophenolase activity of PPO catalyses the oxidation of phenol to o-quinone (step C). o-Quinone can then enter an amplification recycling process involving electrochemical reduction (step E) and enzymatic reoxidation (step C': catecholase activity). The rate-limiting steps such as monophenolase activity, catecholase recycling, permeability of the membrane, and activity and accessibility of the catalytic enzyme sites are theoretically considered and experimentally demonstrated for different electrode configurations including PPO immobilized in Laponite hydrogels and layer-by-layer self-assembled multilayers of PPO and poly(diallyldimethylammonium).